Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306352945> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- W4306352945 endingPage "25" @default.
- W4306352945 startingPage "23" @default.
- W4306352945 abstract "Introduction: Vitiligo is a specific, common, often heritable acquired disorder characterized by well-circumscribed milky white cutaneous macules and patches devoid of identifiable melanocyte. Treatment of vitiligo, though quite frustrating, includes repigmentation therapies like Topical glucocorticoids, Topical calcipotrieinene, Topical PUVA (Psoralen + Ultraviolet Light A). The combination of calcipotriol and PUVA proves quite effective for management of this condition. Objectives: To compare the effectiveness of PUVA and the combination of topical calcipotriol and PUVA in treatment of vitiligo. Materials and Methods: This quasi experimental study was undertaken at Combined Military Hospital, Dhaka Cantonment, Dhaka from March to October 2015. A total of 32 patients suffering from vitiligo diagnosed clinically and confirmed by Wood’s lamp examination were selected as study population. Systemic PUVA, thrice weekly was given but Topical calcipotriol applied twice daily at one side of the body and other side used nothing Topically. Response was assessed clinically every 4 weeks along with photographic record and compared between two sides of the body. Results: During the course of the treatment, the calcipotriol plus PUVA treated side showed considerably better improvement than only PUVA treated side. The response was Excellent; 37.8% (12/32), Good; 31.3% (10/32), Fair; 18.8% (6/32), Poor; 12.5% (4/32) in calcipotriol plus PUVA treated side whereas Excellent; 12.5% (4/32), Good; 25% (8/32), Fair; 43.8% (14/32) and Poor; 18.8% (6/32) in only PUVA treated side. Conclusion: This study shown that concurrent topical calcipotriol potentiates the efficacy of PUVA in the treatment of vitiligo along with the fact that this combination achieves earlier pigmentation with a lower total UVA dosage in comparison to only PUVA therapy. JAFMC Bangladesh. Vol 18, No 1 (June) 2022: 23-25" @default.
- W4306352945 created "2022-10-16" @default.
- W4306352945 creator A5004724360 @default.
- W4306352945 creator A5005285363 @default.
- W4306352945 creator A5025743373 @default.
- W4306352945 creator A5028337529 @default.
- W4306352945 date "2022-10-16" @default.
- W4306352945 modified "2023-09-26" @default.
- W4306352945 title "Role of Topical Calcipotriol to Potentiate the Effect of Photochemotherapy (PUVA) in Treatment of Vitiligo" @default.
- W4306352945 doi "https://doi.org/10.3329/jafmc.v18i1.61252" @default.
- W4306352945 hasPublicationYear "2022" @default.
- W4306352945 type Work @default.
- W4306352945 citedByCount "0" @default.
- W4306352945 crossrefType "journal-article" @default.
- W4306352945 hasAuthorship W4306352945A5004724360 @default.
- W4306352945 hasAuthorship W4306352945A5005285363 @default.
- W4306352945 hasAuthorship W4306352945A5025743373 @default.
- W4306352945 hasAuthorship W4306352945A5028337529 @default.
- W4306352945 hasBestOaLocation W43063529451 @default.
- W4306352945 hasConcept C16005928 @default.
- W4306352945 hasConcept C2776009542 @default.
- W4306352945 hasConcept C2779980618 @default.
- W4306352945 hasConcept C2780200183 @default.
- W4306352945 hasConcept C2780564577 @default.
- W4306352945 hasConcept C2781110370 @default.
- W4306352945 hasConcept C3017420807 @default.
- W4306352945 hasConcept C54355233 @default.
- W4306352945 hasConcept C552990157 @default.
- W4306352945 hasConcept C71924100 @default.
- W4306352945 hasConcept C86803240 @default.
- W4306352945 hasConceptScore W4306352945C16005928 @default.
- W4306352945 hasConceptScore W4306352945C2776009542 @default.
- W4306352945 hasConceptScore W4306352945C2779980618 @default.
- W4306352945 hasConceptScore W4306352945C2780200183 @default.
- W4306352945 hasConceptScore W4306352945C2780564577 @default.
- W4306352945 hasConceptScore W4306352945C2781110370 @default.
- W4306352945 hasConceptScore W4306352945C3017420807 @default.
- W4306352945 hasConceptScore W4306352945C54355233 @default.
- W4306352945 hasConceptScore W4306352945C552990157 @default.
- W4306352945 hasConceptScore W4306352945C71924100 @default.
- W4306352945 hasConceptScore W4306352945C86803240 @default.
- W4306352945 hasIssue "1" @default.
- W4306352945 hasLocation W43063529451 @default.
- W4306352945 hasOpenAccess W4306352945 @default.
- W4306352945 hasPrimaryLocation W43063529451 @default.
- W4306352945 hasRelatedWork W176018810 @default.
- W4306352945 hasRelatedWork W1983458913 @default.
- W4306352945 hasRelatedWork W2007318872 @default.
- W4306352945 hasRelatedWork W2039634279 @default.
- W4306352945 hasRelatedWork W2186514824 @default.
- W4306352945 hasRelatedWork W2189398686 @default.
- W4306352945 hasRelatedWork W2442994023 @default.
- W4306352945 hasRelatedWork W3010549357 @default.
- W4306352945 hasRelatedWork W3027293030 @default.
- W4306352945 hasRelatedWork W4306352945 @default.
- W4306352945 hasVolume "18" @default.
- W4306352945 isParatext "false" @default.
- W4306352945 isRetracted "false" @default.
- W4306352945 workType "article" @default.